Rho family GTPases control cell migration and participate in the regulation of cancer metastasis. Invadopodia, associated with invasive tumour cells, are crucial for cellular invasion and metastasis. To study Rac1 GTPase in invadopodia dynamics, we developed a genetically encoded, single-chain Rac1 fluorescence resonance energy (FRET) transfer biosensor. The biosensor shows Rac1 activity exclusion from the core of invadopodia, and higher activity when invadopodia disappear, suggesting that reduced Rac1 activity is necessary for their stability, and Rac1 activation is involved in disassembly. Photoactivating Rac1 at invadopodia confirmed this previously unknown Rac1 function. We describe here an invadopodia disassembly model, where a signalling axis involving TrioGEF, Rac1, Pak1, and phosphorylation of cortactin, causes invadopodia dissolution. This mechanism is critical for the proper turnover of invasive structures during tumour cell invasion, where a balance of proteolytic activity and locomotory protrusions must be carefully coordinated to achieve a maximally invasive phenotype.
Rho family GTPases control cell migration and participate in the regulation of cancer metastasis. Invadopodia, associated with invasive tumour cells, are crucial for cellular invasion and metastasis. To study Rac1 GTPase in invadopodia dynamics, we developed a genetically encoded, single-chain Rac1 fluorescence resonance energy (FRET) transfer biosensor. The biosensor shows Rac1 activity exclusion from the core of invadopodia, and higher activity when invadopodia disappear, suggesting that reduced Rac1 activity is necessary for their stability, and Rac1 activation is involved in disassembly. Photoactivating Rac1 at invadopodia confirmed this previously unknown Rac1 function. We describe here an invadopodia disassembly model, where a signalling axis involving TrioGEF, Rac1, Pak1, and phosphorylation of cortactin, causes invadopodia dissolution. This mechanism is critical for the proper turnover of invasive structures during tumour cell invasion, where a balance of proteolytic activity and locomotory protrusions must be carefully coordinated to achieve a maximally invasive phenotype.
Tumour invasion requires orchestration of actin-based protrusions capable of extracellular matrix (ECM) degradation and cell locomotion [1] [2] [3] . On epithelial to mesenchymal transformation 4 , tumours gain the ability to invade by protruding invadopodia, characterized by their ability to localize matrix metalloproteinases important for the proteolytic digestion of ECM (refs 5,6) . In breast carcinomas, the ability of cells to form invadopodia and their invasive potential are directly correlated 7 ; thus, understanding the molecular mechanisms regulating invadopodia functions is critical.
Cells assemble and protrude invadopodia during invasion 8 and several members of the p21 Rho family of small GTPases, including Cdc42, RhoA and RhoC, are involved 9, 10 . These GTPases cycle between a GTP-loaded 'ON' versus a GDP-loaded 'OFF' state 11 . Regulators controlling these states include guanine nucleotide exchange factors (GEF), GTPase activating proteins (GAP), and guanine nucleotide dissociation inhibitors 12 (GDI). Cdc42 is crucial for invadopodia formation by activating neuronal Wiskott-Aldrich Syndrome protein (N-WASP), on which other invadopodia core proteins are assembled 13 . RhoC regulates invadopodia integrity by confining actin protrusion within the invadopodium 10 . RhoA is involved in the delivery of vesicles containing membrane type 1 matrix metalloproteinases to degradation sites 10, 14 , and other functions associated with the actin cytoskeleton 9 . The mechanism by which these GTPases regulate their respective downstream functions at the invadopodia is spatially distinct 10 . This suggests that the spatiotemporal dynamics of Rho GTPase activations at or surrounding invadopodia are critical, yet not much is known about such dynamics of other Rho isoforms, specifically Rac1. Previous studies indicated that Rac1 overexpression and hyperactivity lead to aberrant cell motility and metastatic phenotypes [15] [16] [17] [18] [19] [20] [21] . Rac1 was necessary for invasive protrusions in human melanomas 22 , and MCF10A breast epithelial cells required Rac1 for TGF-β-dependent matrix degradation 23 . Rac1 was also required for invasion in Rastransformed melanoblasts 24 . Although Rac1 seems to be required for pro-invasive functions in these cases, there is not yet a clear study of Rac1 during invadopodia functions at subcellular scales. A number of studies have begun to address this question 22, 23, 25 , and have shown evidence that Rac1 activation may drive invadopodia. However, this has never been directly observed, only indirectly inferred on the basis of traditional experimental methods. Invadopodia are highly regulated and transient subcellular structures, and Rac1 has equally fine spatiotemporal activation dynamics within cells 26 , making it difficult to accurately study using more conventional approaches.
To address this problem, we developed a FRET-based biosensor for Rac1. The biosensor enables direct visualization of Rac1 activities at subcellular resolution and on a timescale of seconds, while maintaining a single-chain structure and correct isoprenylation. Using this biosensor in combination with the focal photo-uncaging of Rac1 (ref. 27 ), we report a mechanism by which invasive breast carcinomas A R T I C L E S disassemble their invadopodia through Trio-Rac1 activation, through cortactin phosphorylation by p21 activated kinase 1 (Pak1). Here we report the involvement of Rac1 in invadopodia turnover, which could be essential in proper regulation of invasive protrusions during invasion and metastasis.
RESULTS

Rac1 restricts matrix-degrading invadopodia activity
To determine the requirement for Rac1 in invadopodia formation and function, we first silenced Rac1 in MTLn3 rat mammary adenocarcinoma cells 28 and assayed for matrix degradation activity 10 . On Rac1 depletion 28 ( Fig. 1a) , degradation of extracellular matrix is markedly increased compared with control short interfering RNA (siRNA)-treated cells (Fig. 1b,c) , suggesting that Rac1 controls invadopodia activity. This was recapitulated when Rac1 inhibitor NSC23766 was used (Fig. 1c,d ). This is recapitulated in human MDA-MB231 and BT549 metastatic cell lines [29] [30] [31] , but not in the MCF10A normal human breast epithelial cell line 32 ( Supplementary Fig. 1a-g ). MTLn3 express Rac1 and Rac3, but not Rac2 (Fig. 1e ). Rac1 RNAmediated interference (RNAi) did not affect Rac3 expression levels ( Fig. 1e) , and multiple single siRNA oligonucleotides also resulted in the observed phenotype ( Supplementary Fig. 1h ). Enhanced degradation from Rac1 knockdown was probably not due to lack of cell motion, as the relative invadopodia lifetimes in these conditions were greatly increased, but the average number of invadopodia per cell at any one point in time remained the same ( Fig. 1d and Supplementary Video 1). These results suggest that Rac 1 activity seems to restrict invadopodia lifetime as well as matrix degrading activity.
A single-chain Rac1 biosensor
Biochemical approaches cannot be used for observing Rac1 activity at invadopodia; we produced a genetically encoded single-chain Rac1 biosensor. A full-length Rac1 was placed at the carboxy terminus of the biosensor to maintain the hypervariable region and the correct lipid modification motif, important for plasma membrane and GDI interactions, similar in design to the previous RhoA biosensor 33 ( Fig. 2a,b) . GDI interaction is the main difference to the previousgeneration Rac1 biosensor, reflecting the regulatory cycle of Rac1 in sensor readouts 34, 35 . The sensor consists of a monomeric Cerulean, two tandem p21-binding domains (PBD) of Pak1, separated by a structurally optimized 14 amino-acid linker chain, monomeric Venus, and full-length Rac1. The tandem PBD allows for autoinhibitory mechanism of Pak1 by maintaining the autoregulatory moiety (amino acids 70-149; ref. 36) . The second PBD contains H83D-H86D GTPase-binding mutations to prevent spurious interactions with other GTPases when the biosensor is activated and the autoinhibition is relieved (Fig. 2c) .
As the size of the biosensor precluded in vitro purification, we overexpressed it in HEK293 cells and analysed the fluorescence spectra of mutant versions of the biosensor as previously described 33 .
Compared with wild-type (WT), the constitutively active (G12V and Q61L) mutants had a higher emission ratio (FRET/CFP), and the inactive mutants (T17N and T35S) had a reduced emission ratio. Co-expression of threefold excess GDI produced a reduced FRET ratio as expected in WT and G12V mutant versions of the biosensor (Fig. 2d,e) .
When co-transfected with excess GDI, GEFs that are known to activate Rac1 (ref. 37) rescued Rac1 activity, but non-Rac1 GEFs did not rescue activity (Fig. 2f) . Similarly, p50RhoGAP inhibited Rac1 activity, but the control Rap1GAP did not (Fig. 2f) . These data show that the biosensor behaves accurately and is regulated by upstream regulators. The overexpression of G12V and T17N versions of the biosensor in MEFs shows that the in-cell difference in the FRET ratio based on imaging is approximately 40%, similar to the fluorometric analysis (Fig. 2g) . In versions of the biosensor where both PBDs were mutated (H83D-H86D), FRET was reduced to dominant-negative and GDI-inhibited levels (Fig. 2h ).
Rac1 activity is excluded from invadopodia
We produced an MTLn3 cell line stably incorporating the Rac1 biosensor under tet-OFF regulation to limit the biosensor expression to ≤20% of endogenous Rac1 ( Fig. 2i; refs 33,38) . We stimulated cells with EGF, triggering invadopodia precursor formation 8 and observed Rac1 activity during early events. After stimulation, structures containing cortactin fluorescence appeared and remained throughout the 10-min duration of imaging, accompanied by a pronounced depletion of Rac1 activity within the invadopodium core (Fig. 3a,b and Supplementary Video 2). This exclusion of Rac1 activity was not due to loss of Rac1 from the invadopodia, as endogenous Rac1 or CFP-Rac1 is uniformly distributed (Fig. 3c and Supplementary Fig. 2a) . A similar reduction in Rac1 activity was observed in fixed cells using Cy5-dyelabelled cortactin (Fig. 3d) . MDA-MB-231 cells also show reduced Rac1 activity at invadopodia (Fig. 3e,f) . Accumulated cortactin puncta are non-vesicular 39 and degrade matrix ( Supplementary Fig. 2b ,c). We examined how Rac1 is involved in invadopodia maintenance by observing Rac1 activity in steady-state invadopodia over a period of 3 h. We began imaging pre-formed invadopodia and examined Rac1 activity throughout their lifetimes. We observed that when a stable invadopodium is present, Rac1 activity inside the invadopodium is significantly lower when compared with the region just outside (Fig. 3b) , until the invadopodium disappears ( Fig. 3g and Supplementary Video 3). At this point Rac1 activity is elevated ( Fig. 3h and Supplementary Fig. 2d ). This suggests that Rac1 activation could be associated with disassembly of invadopodia. As a control we compared this Rac1 activity profile to RhoA activity 33 . As shown previously for EGF-induced invadopodia 10 , steady-state RhoA activity also showed no significant changes ( Supplementary Fig. 2e ).
Focal activation of Rac1 disassembles invadopodia
To determine whether Rac1 activation triggers invadopodia disassembly, we used photoactivatable Rac1 (PA-Rac1; ref. 27) to activate Rac1 at pre-formed invadopodia and observe how it influences their dynamics. After photoactivation using 1-s pulses of 457 nm light every 30 s to MTLn3 cells expressing PA-Rac1 and two invadopodia markers (mTagRFP-cortactin and GFP-Tks5; ref. 40) , the invadopodium that was photoactivated disappears within 6 min of the start of the irradiation, at the same time the uncaged Rac1 produces a lamellipodium protrusion next to the photoactivated region (Fig. 4a,c and Supplementary Video 4) . Approximately 80% of invadopodia analysed disappear on focal photoactivation of Rac1 (Fig. 4d) and Tks5-GFP co-localization spots. n = 9 invadopodia for each condition, pooled from 3 independent experiments; error bars are s.e.m. Student's ttest was used. P = 0.418134 (number of invadopodia per cell, control versus Rac1 siRNA), P = 0.115958 (number of invadopodia per cell, control versus NSC23766), **P = 6.531 × 10 −27 (invadopodia lifetime Pak1-cortactin axis propagates Rac1-dependent invadopodia disassembly As the evidence pointed to Rac1 inducing invadopodia disassembly, we investigated downstream targets. Two well-studied Rac1 effectors are the Paks and the Wave protein family 18 . Previously Wave was shown to have no effect on invadopodia 13 , but Pak was not studied in this context. High levels of Pak1 are correlated with tumour invasiveness 41 . Previous studies showed that inactive Pak1 is constitutively associated with cortactin in a manner that is independent of Rac1 (ref. 42) , and when activated by a GTPase, Pak1 phosphorylates cortactin on Ser 113, causing the release of cortactin from F-actin 43 to induce turnover of podosomes 44 . As Pak1 is one of the main downstream effectors of Rac1 activity is lower inside invadopodia and higher outside, whereas cortactin accumulation is high inside and low outside. n = 19 invadopodia, pooled from 3 independent experiments, with s.e.m. Student's t-test: **P = 1.2486 × 10 −10 (cortactin), **P = 2.82709 × 10 −5 (Rac1). (g) Representative biosensor-expressing MTLn3 cell at steady state with TagRFP-cortactin marker. Close-up of pre-formed invadopodium (T = X), and later time point when the invadopodium disappeared (T = X + 24 min). Scale bar, 2 µm. Representative images are shown from 50 cell movies. (h) Close-up of another invadopodium in its final stages. White and black circles show the invadopodium location and corresponding Rac1 activity levels. Left: steadystate invadopodia and associated reduced Rac1 activity. Middle: moment of elevated Rac1 activity at the core of invadopodia just before disappearance. Right: the same region after the disappearance of invadopodia. Scale bar, 2 µm. Representative image sets are shown from 4 cell movies that showed elevated activity of Rac1 before invadopodia disappearance. Total steadystate cell movie sets = 50. Rac1, we suggested a direct role in linking Rac1 to invadopodia breakdown. Immunofluorescence indicated that endogenous Pak1 co-localizes with cortactin at mature, degrading invadopodia ( Fig. 5a ), even when Rac1 is depleted ( Supplementary Fig. 3a) . Next, we used RNAi against Pak1 ( Fig. 5b and Supplementary   Fig. 1h ), recapitulating the results of Rac1 knockdown by increasing matrix degradation ( Fig. 5c and Supplementary Fig. 1a-d) . Invadopodia formation was unaffected by Pak1 siRNA, with no change in average invadopodia per cell, but invadopodia lifetime increased (Fig. 5d) . Collectively, these results implicated Pak1 as the immediate downstream target of Rac1 at the invadopodia to mediate disassembly.
A R T I C L E S
To determine whether Pak1 is involved in this pathway, we silenced Pak1 and observed invadopodia dynamics on focal uncaging of Rac1. Uncaging PA-Rac1 in the Pak1 knockdown background did not cause the disappearance of invadopodia (approximately 19% invadopodia disappearance), but produced edge ruffling and a lamellipodium ( Fig. 5e; Supplementary Fig. 3e and Video 6).
After establishing the Rac1-Pak1 link, we examined whether the phosphorylation of cortactin by Pak1 was important. Focal uncaging of PA-Rac1 with an overexpressed mTagRFP-cortactin containing a non-phosphorylatable point mutation (S113A) where Pak1 is known to phosphorylate cortactin 43, 45 disassembled the invadopodia only 30% of the time, but the leading edge ruffling and lamellipodia protrusions were unaffected ( Supplementary  Fig. 3b,e and Video 7) . Expression of the cortactin mutant alone (f) Quantification of mean invadopodia lifetime in control and TrioGEFsiRNA-treated cells, from time-lapse movies over a period of 6 h (left) and average number of invadopodia per cell (right). Invadopodia lifetime was quantified as the time in minutes from the appearance to the disappearance of RFP-cortactin and Tks5-GFP co-localized spots. n = 11 invadopodia for each condition pooled from 3 independent experiments, error bars are s.e.m. Student's t-test was used. **P = 6.2151 × 10 −10 , P = 0.380125939 (number of invadopodia per cell). Uncropped images of blots are shown in Supplementary Fig. 9 .
increases matrix degradation similar to depletion of Rac1 or Pak1 ( Supplementary Fig. 3c ), and increases invadopodia lifetime ( Supplementary Fig. 3d) .
Moreover, we used the proximity ligation assay (PLA) between cortactin and phospho-serine to measure the total phospho-serine levels of cortactin at invadopodia demonstrating whether the Rac1-Pak1 pathway leads to changes in the total phospho-serine content of cortactin at invadopodia in situ. Total cortactin phosphoserine is reduced significantly when Pak1 was silenced, supporting the link between Pak1 and cortactin ( Supplementary Fig. 3f,g ).
These results suggest that the Rac1-Pak1 pathway probably produces a destabilization of invadopodia structures through serine phosphorylation of cortactin.
TrioGEF activates Rac1 at invadopodia to induce disassembly
Spatial regulation of GTPases is crucial to their function and because they are activated by GEFs, we sought to determine which GEF may activate Rac1 at invadopodia for disassembly. First, we used the Rac1-inhibitor NSC23766, which inhibits Rac1 activation by TrioGEF and Tiam1 (ref. 46) , and performed an invadopodia lifetime study over a 6-h time period. Untreated cells had average invadopodia lifetimes of 30 min (range: 14 min-2 h), measured by mTagRFP-cortactin and Tks5-GFP co-localization (Fig. 6a and Supplementary Video 8) . In NSC23766-treated cells, invadopodia did not disappear during the time frame of image acquisition (Fig. 6a and Supplementary Video 9) . We used another Rac1-inhibitor Z62954982, which inhibits Rac1-Tiam1 interaction but not TrioGEF (ref. 47) . The distribution of invadopodia lifetimes was similar to the control after the Z62954982 treatment, suggesting that Trio may activate Rac1 at invadopodia ( Fig. 6a and Supplementary Video 10). Endogenous TrioGEF is localized to invadopodia (Fig. 6b) , but endogenous Tiam1 does not ( Supplementary Fig. 4a ). No Tiam1-GFP accumulated at invadopodia ( Supplementary Fig. 4b) , and a dominant-negative mutant Tiam1 (ref. 48 ) did not affect invadopodia functions (Supplementary Fig. 4c ). Furthermore, silencing TrioGEF ( Fig. 6c and Supplementary Fig. 1h ) recapitulates the increase in degradation and invadopodia lifetimes (Fig. 6d,e and Supplementary Fig. 1a-d) , but the average number of invadopodia per cell does not change (Fig. 6f) , similar to the Rac1 RNAi result. We overexpressed the constitutively activated (Trio-D1SH3; ref. 49 ) and dominant-negative (N1406A-D1407A) form of the same Trio-D1SH3 (ref. 50) , and observed that the active form reduced matrix degradation, but the dominant-negative form produced increased degradation (Fig. 6e) . Full-length WT, dominantnegative, and the short dominant-negative Trio-D1SH3 are present in about 20% of invadopodia, but the Trio-D1 SH3-dominant-negative form lacking the tandem SH3 domain cannot localize at invadopodia, and EGF stimulation does not affect the localization of full-length Trio ( Supplementary Fig. 5a-c) . This means that Trio is recruited transiently to invadopodia through its SH3 domain at DH-PH-1 ( Supplementary Fig. 5d ) because less than 30% of invadopodia have Trio accumulation. Moreover, Trio is increased at invadopodia when endogenous Rac1 is silenced ( Supplementary Fig. 5e ), probably as a consequence of its disassembly defect. Trio knockdown lowers the global Rac1 activity levels in cells (Fig. 7a,b) , making the difference between the inside and outside of invadopodia less pronounced (Fig. 7c) . Furthermore, we performed PLA under Trio knockdown and found that the total phospho-serine levels on cortactin at invadopodia decreased significantly( Supplementary Fig. 3f,g ).
An invadopodia-associated complex of cortactin, paxillin and PKC has been shown previously 51 , and the Git1-Pix-Pak complex can be recruited to paxillin through Git1 (ref. 52) . Pix proteins are GEF for Rac1 and Cdc42 (ref. 53) . α-and β-Pix both localize to invadopodia and this recruitment is unaffected by EGF stimulation; however, knocking down either of the endogenous pix isoforms reduced the amount of matrix degradation ( Supplementary Fig. 6a-e) . As this is the opposite phenotype to Rac1, Pak1 or TrioGEF knockdowns, the Pix proteins are probably involved during other aspects of invadopodia dynamics, but not in disassembly. Moreover, paxillin does not accumulate in the core of the invadopodia, suggesting that Pip localization at invadopodia is not paxillin-mediated (Supplementary Fig. 6f ).
Trio-Rac1-Pak1 axis impacts invasion in three-dimensional environment
The pro-invasive role of Rac1 in aggressive tumours is documented in a number of systems [15] [16] [17] [18] [19] [20] . We sought to determine whether the Trio-Rac1-Pak1 axis impacts three-dimensional (3D) invasion. Invasion is significantly impacted when Trio, Rac1 or Pak1 is silenced in metastatic tumour cells but not in MCF10A cells (Fig. 8a and Supplementary Fig. 1a-f) . Motility in 3D collagen matrices is significantly impaired on Rac1, Pak1 or Trio depletion (Fig. 8b-d) . Furthermore, matrix degradation in 3D is increased in the absence of the Trio-Rac1-Pak1 axis (Fig. 8e,f) , suggesting that the same mechanism that aberrantly enhances the matrix degradation in 2D also operates under 3D conditions. These results suggest that proper coordination of matrix degradation and locomotory protrusions is required for efficient invasion in 3D environment.
DISCUSSION
We report the localized activation dynamics of Rac1 directly regulating the stability and disassembly of invadopodia through Pak1 and cortactin phosphorylation in metastatic breast carcinomas (Fig. 8g) . We show that TrioGEF activates Rac1 at invadopodia, and this Trio-Rac1-Pak1 cascade is regulated independently from the lamellipodia compartment. This is probably through different immediate downstream effectors, because depleting either Trio or Pak1 did not abrogate EGF-stimulated lamellipodia protrusion, but depleting Rac1 did (Supplementary Fig. 7a ). Importantly, we provide conserved observations for the Trio-Rac1-Pak1 axis in metastatic breast carcinomas but not in normal epithelial cells; a critical distinction in the signalling mechanisms used to affect efficient invasions between malignant versus normal cells.
As invadopodia are transient subcellular structures, we approached the problem by building a biosensor for Rac1. The fundamental difference between our sensor and the previous-generation system 34 is that the latter is constitutively anchored to the plasma membrane through the k-Ras CAAX box 34, 35 , producing GEF-GAP sensors. In our system the sequestration by GDI is correctly taken into account 33 . Our data and other studies suggested that invasive tumours use two separate downstream signalling pathways to achieve efficient migration on Rac1 activation. The lamellipodia driven by Rac1 is Wave2-dependent 13, 54 ; indeed, we show here that in a Pak1-silenced background, photoactivation of Rac1 at an invadopodium does not result in its disassembly, and edge ruffling and lamellipodia protrusions are unaffected. The mechanism by which Pak1 enhances the turnover of invasive processes agrees with other studies suggesting Pak1 inducing the turnover of podosomes 43, 44 , and cortactin phosphorylation by Pak destabilizing F-actin-cortactin association 43 . These studies and our results support the idea that the Rac1-Pak1 axis induces the turnover of many of these adhesive and invasive processes, including focal adhesions [55] [56] [57] . Invadopodia formation is a multistep process 8 . Efficient turnover of invadopodia seems critical to effective invasion. Previously, focal adhesion kinase was reported to antagonize c-Src to regulate the total number of invadopodia in MTLn3 cells; thus, overexpression of c-Src can produce greater numbers of structures 58 . We show that the number of structures is independently regulated by c-Src (refs 8,58,59) and not the Trio-Rac1-Pak1 axis ( Supplementary Fig. 7b,c) .
Cancer invasion in vivo is a complex process involving localized regulations of signalling proteins, including GTPases. GEFs are established spatial activators of GTPases (ref. 37) . The specific mechanism of TrioGEF control is not well known; however, we established a role for Trio as the activator of Rac1 at invadopodia. Trio contains two DH-PH domains, which target RhoG and Rac1, or RhoA (ref. 60) . In glioblastoma, RhoG is involved in invadopodia formation 25 . In breast carcinoma, siRNA of RhoG has no effect on matrix degradation nor does RhoG accumulate at invadopodia (Supplementary Fig. 8) . The difference could be because glioblastoma is not derived from epithelium and invades brain tissue locally; thus, the ECM environment is much different in brain than epithelium 61 . We showed that the SH3 domain of Trio is required for transient invadopodia localization (Supplementary Fig. 5d ). These observations clearly point to the importance of localized regulation of GTPases within subcellular compartments; indeed, when TrioGEF was silenced, overall Rac1 activity was reduced by approximately 20% (Fig. 7) . Although this had no effect on EGF-stimulated leading edge protrusion ( Supplementary Fig. 7a ), it clearly impacted invadopodia as both the lifetimes and matrix degradation were significantly altered. Thus, the functional regulation of how Trio activates Rac1 only at a specific time and in a context of invadopodia disassembly needs to be further explored. Also, other mechanisms may cooperate with the Trio-Rac1-Pak1 axis during turnover of invadopodia 59 . On the basis of our observations, we propose two models where the Rac1-mediated disassembly of invasive protrusions could be advantageous for tumour cells. In 3D invasion in vivo, invadopodia and lamellipodia compartments converge into a single leading front 62 . Rac1 activation at the leading front propagates through two separate downstream effector pathways to mediate: disassembly and clearance of components necessary for matrix degradation (through Pak1); and simultaneously, extend protrusions with locomotive characteristics as opposed to degradative (through Wave2). This is an efficient mechanism for switching between these two characteristics by a single upstream regulator. This model is consistent with reports of Rac1 producing pro-invasive phenotypes 20 , because an ability to increase the invadopodia turnover could enhance the ability of tumours to switch rapidly between invasive versus locomotive protrusions. Indeed, cells depleted of Trio-Rac1-Pak1 have motility defects in 3D matrices (Fig. 8a-d) . Alternatively, invasive cells in vivo continuously probe the microenvironment within the ECM to detect regions optimal for invasion 63 . Thus, microenvironmental cues could provide feedback to drive the turnover of degradative protrusions through regulation of localized Rac1 activity modulating the local turnover rates of lamellipodia versus invadopodia. In both models, our observations are consistent with the idea that the turnover of invadopodia is directly regulated through a mechanism activated by Rac1. Under normal conditions, invasive and locomotory protrusions are both cyclical and coordinated, where the end of one is coupled to the start of the other. Thus, when one component is perturbed, the entire cell motility cycle and the invasion machinery become stalled, resulting in aberrantly increased local matrix degradation (Fig. 8e,f) but impaired overall invasion and motility in 3D (Fig. 8a-d) . This coordination is critical to efficient invasion and migration in 3D where all pieces of the system need to be functional, unlike in stimulated protrusions in 2D where the initial phase of protrusion formation can be unaffected by Pak1 or Trio depletion but not Rac1 ( Supplementary  Fig. 7a) . By enhancing the turnover dynamics of invadopodia, Rac1 contributes to efficient cycling of matrix degradation versus locomotory protrusions in invasive tumours, allowing for facile cell migration in 3D.
A R T I C L E S
METHODS
Methods and any associated references are available in the online version of the paper. 
Cell lines.
MTLn3 were cultured and transfected as previously described 10 . MDA-MB-231 (ATCC HTB-26) and BT-549 (ATCC HTB-122) were cultured in DMEM with 10% fetal bovine serum (FBS), antibiotics (Invitrogen) and insulin (for BT-549) (Invitrogen) as suggested by ATCC.
MCF10A (ATCC CRL 10317) were cultured following the ATCC protocols. MCF10A were transfected as previously described 23 . MDA-MD-231 and BT-549 were transfected by nucleofection according to manufacturer's protocols (Lonza).
All cell lines were mycoplasma tested.
Intramolecular biosensor for Rac1. The biosensor for Rac1 was subcloned within the multiple cloning site (MCS) of pTriEX-His-Myc4 (Novagen) between the NcoI and XhoI restriction sites. The construct consisted of the monomeric Cerulean (mCerulean) fluorescent protein 66 , a BamHI restriction site, two tandem p21-binding domains (PBD; amino-acid residues 70-149) from Pak1, separated by a HindIII restriction site and GSGGPPGSGGSG linker, the monomeric Venus (mVenus) fluorescent protein 67 , an EcoRI restriction site, a full-length Rac1, and a XhoI site immediately following the stop codon. mCerulean was subcloned between the NcoI and BamHI MCS restriction sites using the primer pair 5 -CCATGGTGAGCAAGGGCGAGGAG-3 and 5 -GGATCCTTTGTACAGCTC GTCCATG-3 . The first PBD was subcloned between the BamHI and HindIII sites using the primer pair 5 -GGATCCAAAGAGCGGCCAGAGATTTCTCT-3 and 5 -AAGCTTTCCGCCAGACCCTGACTTATCTGTAAAGCTCATGTAT-3 . The second PBD with H83D and H86D GTPase-binding-deficient point mutations was subcloned between the HindIII and NotI sites using the primer pair 5 -AAGCTTCCACCAGGGTCTGGAGGCTCCGGGAAAGAGCGGCCAGA GATTTCTCTCC-3 and 5 -GCTTCCGCTGACTTATCTGTAAAGCTCATG-3 . Point mutagenesis was performed using the Quikchange PCR mutagenesis kit (Stratagene).
mVenus was subcloned between the NotI and EcoRI sites using the primer pair 5 -GCGGCCGCAATGGTGAGCAAGGGCGAGGAGCT-3 and 5 -CTTGTACAG CTCGTCCATGCCGAATTC-3 . Full-length Rac1 was subcloned between the EcoRI and XhoI sites using the primer pair 5 -GAATTCATGCAGGCCATCAA GTGTGTGG-3 and 5 -TTACAACAGCAGGCATTTTCTCTCGAG-3 .
For production of the tetracycline-inducible retroviral construct, the entire biosensor cassette was cut out of the pTri-EX backbone using NcoI and XhoI restriction sites, blunt-ended, and ligated into the multiple cloning site of the pRetroX-Tight-Pur vector (Clontech) at the NotI site that was blunt-ended.
The design of the biosensor is such that the built-in binding domain does not compete against the binding of endogenous targets by the activated biosensor (Fig. 2c) . This feature is critical to reducing potential dominant-negative or overexpression artefacts.
Biosensor validation-fluorometry assay. The biosensor expression construct was transfected into LinXE cells plated 8 × 10 5 overnight over poly-L-lysine in 6-well plates, using Lipofectamine Plus (Invitrogen) according to the manufacturer's protocols. The total amount of DNA was 700 ng per well. In cases where the biosensor was co-transfected with upstream regulators, the biosensor/GDI ratio was 1:3, and the biosensor/GDI/GEF ratio was 1:3:1-2. At 48 h after transfection, cells were fixed with 3.7% formaldehyde in PBS and their fluorescence spectrum was measured using a MicroMax plate reader attached to a Fluororlog MF2 spectrofluorometer (Horiba Jobin Yvonne). Cells were excited at 433 nm and a fluorescence emission spectrum was measured between 450 and 600 nm. Background autofluorescence was subtracted from the raw spectra, and normalized to CFP emission at 475 nm as previously described 33 .
Invadopodia degradation assay. All imaging experiments were performed as previously described 10, 68 . Alexa-568 or -405-conjugated thin gelatin matrix (Invitrogen) was prepared on MatTek dishes (MatTek) as previously described 69 . Gelatin degradation was measured by quantifying the average area of nonfluorescent pixels per field. Approximately 15 random fields were imaged per condition and each independent experiment was performed at least 3 times and averaged. Invadopodia were identified by cortactin and Tks5 staining and manually counted from images.
Reagents and antibodies. mTagRFP-cortactin has been previously described Tiam-1 PH-CC-Ex (amino acids 431-670) competitive inhibitor 48 was PCR amplified from the mouse full-length GFP-Tiam-1 by using the primer set 5 -GC CATATATTTGGCCATATTCTCGAGCTCAGGGCACTGTGCGGAAGGCTGGA G-3 and 5 -GCAATTATATTGACCTAAAGAATTCTTAAGTCCGGGCTGCCAC CAGGGCATGA-3 and ligated into XhoI-EcoRI sites within the multiple cloning site of pEGFP-C1 backbone (Clontech). The Tiam-1 catalytically dead dominant-negative mutant (L1200R-L1201S) version was produced by site-directed mutagenesis using the primer pair 5 -GCGCAAACAGCTCCCTGCTCCGAA GCGGGTACTTGAGG-3 and 5 -CCTCAAGTACCCGCTTCGGAGCAGGGAGC TGTTTGCGC-3 .
The TrioGEF dominant-negative catalytically dead (N1406A-D1407A) version was produced by site-directed mutagenesis using the primer pair 5 -CTG AGGTGCATGGCAGCAGCGGCTCGCTTCGGCAC-3 and 5 -GTGCCGAAGCG AGCCGCTGCTGCCATGCACCTCAG-3 .
Full-length α-Pix-GFP was a kind gift from G. Rosenberger 64 . Full-length wild-type c-Src-GFP, constitutively activated Y528F c-Src-GFP and the dominant-negative K296R-Y528F c-Src-GFP were kind gifts from M. Way 
Stable cell lines.
The Tet-inducible Rac1 biosensor-expressing MTLn3 cell line was generated by using GP2-293 packaging cells to produce retrovirus for infection. MTLn3 parental cells were stably transduced under G-418 selection with the Retro-X Tet-Off Advanced retroviral vector system (Clontech) as previously described 10 . The Tet-Off MTLn3 cells were transduced again using the retrovirus produced from GP2-293 cells transfected with the pRetroX-Tight-Pur viral vector containing the biosensor within its MCS, and the stable transductants were selected using puromycin at 10 µg ml −1 as previously described 33 , in the presence of 2 µg ml −1 doxycycline to repress the biosensor expression. The cells were then FACS sorted to obtain a population of uniform but low biosensor expression levels. For imaging experiments, cells were induced by removing the doxycycline as previously described 33 . Appropriate biosensor expression levels (≤20% of endogenous Rac1) were achieved at 24 h following the induction. For live-cell imaging, additional constructs, when required, were transiently transfected into induced cells 16 h before the start of the assays using Lipofectamine 2000 reagent (Invitrogen) following the manufacturer's protocols.
Live-cell imaging. MTLn3 cells stably expressing the Rac1 biosensor were induced and transfected with mTagRFP-cortactin 8 and plated on thin-gelatin-matrix-coated glass coverslips 16 h before imaging. For EGF-stimulation experiments, cells were starved for 3 h before image acquisition in L15 medium (Invitrogen) supplemented with 0.35% BSA, then treated with 5 nM EGF for stimulation. Imaging was performed in L15 medium with 5% FBS and Oxyfluor reagent (Oxyrase), in a closed chamber for steady-state experiments.
Rac1 activation levels were measured in living cells by monitoring the ratio of FRET to mCerulean emissions, following previously described methods 33 , then mTagRFP-cortactin images were acquired at each time point. Time-lapse sequences were acquired on a custom Olympus IX81ZDC inverted microscope with a beam splitter that enabled simultaneous acquisitions of both FRET and CFP channels using two Coolsnap ESII CCD (charge-coupled device) cameras (Roper Photometrics) mounted on the left side 100% throughput port through an Olympus beam-splitter module, and a set of excitation-emission filter wheels to direct the mTagRFP emission to a third Coolsnap HQII camera (Roper Photometrics) mounted on the bottom 100% throughput port of the microscope. Images were obtained using an Olympus ×60 PlanApoN 1.45 NA UIS2 DIC lens and Metamorph software. The primary fluorescence dichroic turret used a 10/90 reflection/transmittance mirror (Olympus) that provided the compatibility for all of the band-pass filter sets used. Cells were illuminated with a 100 W Hg lamp through a 10% transmittance neutral density filter. At each time point, mCerulean and FRET images were recorded simultaneously for 700 ms with binning 2 × 2. An mTagRFP-cortactin image was then acquired with 500 ms exposure at 2 × 2 binning.
Invadopodia lifetime was measured in MTLn3 cells expressing TagRFPcortactin and Tks5-GFP, plus various experimental conditions. Cells were plated on thin gelatin matrix and imaged for 6 h with 2 min between frames. Lifetime was quantified by measuring the time from appearance of cortactin and Tks5 colocalized spots to time of disappearance.
Image processing. Metamorph software (Molecular Devices) was used to perform image analysis, as previously described 33 . Briefly, images were dark-current, shading-corrected and background-subtracted, followed by a nonlinear coordinate transformation to achieve a pixel-by-pixel matching of all three camera channels. Binary masks generated through intensity thresholding were applied to each emission channels, and the matched FRET and mCerulean image sets were then ratioed to depict Rac1 activation throughout the cell. A linear pseudocolour lookup table was applied, and the ratio values were normalized to the lower scale value. The ratio was corrected for photobleaching using a previously described approach 33 .
Photoactivation. MTLn3 cells were triple-transfected with photoactivatable Rac (PA-Rac; ref. 27) fused to mTagBFP, mTagRFP-cortactin, and Tks5-GFP using Lipofectamine 2000, one day before imaging, and plated on thin-gelatin-coated glass coverslips overnight. Spots (3 nm) where invadopodia were present were irradiated with 1 s pulses of 457 nm light, every 30 s. Cortactin and DIC images were acquired every 5 s for 10 min. Metamorph software was used to measure RFP and GFP intensities.
Invasion assay.
A Transwell invasion assay (number 354483 BD, Bioscience) was performed and analysed as previously described 10 .
Three-dimensional motility and matrix degradation assay. Preparation of 3D
cultures was done as previously described 68 . 3D motility experiments were performed using a Delta Vision microscope under a ×20 magnification objective lens and imaged every 5 min for 6 h.
For DQ-collagen degradation experiments, imaging was performed using a Leica SP5 confocal microscope with a ×20 magnification objective lens. Cells were cultured in a mixture of collagen-Matrigel-DQ-collagen 3D matrices for 16 h before fixation and staining with DAPI. Z-stacks of 100 µm depth at 5 µm Z-increments were acquired and the DQ-collagen degradation index was calculated as summation of the mean florescence intensity per Z-slice over the total number of planes per field in the DQ-type I collagen channel.
Proximity ligation assay. MTLn3 cells were plated on gelatin matrix, fixed, permeabilized, and stained with primary antibodies for cortactin and pSerine and Phalloidin 488.
The proximity ligation assay was performed according to manufacturer's instructions for the Duolink II Probe anti-rabbit PLUS, PLA probe anti-mouse MINUS, and detection reagent orange (Olink Bioscience).
Statistical analysis.
All P values were determined using a Student t-test. No statistical methods were used to pre-determine the sample size; no vertebrate animals were involved. No randomizations were used. The investigators were not blinded to allocation during experiments and outcome assessment. Statistical tests used are stated in every figure legend with P values as appropriate. Data distribution should meet the normal distribution requirements. No estimate of variation.
C O R R I G E N D U M
A Trio-Rac1-Pak1 signalling axis drives invadopodia disassembly Supplementary Figure 3 Pak1 is recruited to invadopodia in Rac1-depleted cells, photo-uncaging of Rac1 at invadopodia containing phosphorylation deficient cortactin, and Pak1 modulates serine phosphorylation of cortactin, (A) Representative image of MTLn3 cell transfected with Rac1 siRNA, then plated on Alexa-405 conjugated gelatin and fixed and stained with cortactin and Pak1 antibodies to show endogenous protein localization. Arrows point to sites of mature, degrading invadopodia. Scale bar=10μm. Representative image set is from 30 image sets. (B) Representative images of MTLn3 cell transfected with PA-Rac1, S113A TagRFP-cortactin, and Tks5-GFP before and after photoactivation. Blue circles show photoactivated region. Blue arrows point to invadopodia after photoactivation. Scale bars=10μm. Representative image set is shown from 51 image sets. (C) Expression of cortactin S113A mutant alone increases matrix degradation area. Quantification of mean degradation area of control and cortactin mutantoverexpressing cells plated on fluorescent matrix overnight. n=30 fields, pooled from 3 independent experiments, with S.E.M. Student's t-test was used. **p=3.7571x10 -5 . (D) Quantification of mean invadopodia lifetime in control and cortactin S113A overexpressing cells, from time-lapse movies over a period of 6 hours. Invadopodia lifetime was quantified as the time in minutes from the appearance to the disappearance of RFP-cortactin and Tks5-GFP co-localized spots. n=11 invadopodia for each condition, pooled from 3 independent experiments, error bars are S.E.M. Student's t-test was used. **p=9.193x10 -13 . (E) Quantification of percentage of invadopodia that disappear as a result of photoactivation with PA-Rac1, in control, Pak1 knockdown, and cortactin S113A mutant conditions. n=46 invadopodia (PA-Rac) pooled from 3 independent experiments, n=27 invadopodia (Pak1 siRNA) pooled from 3 independent experiments, n=61 invadopodia (Cortactin S113A) pooled from 3 independent experiments, error bars are S.E.M. Student's t-test was used. **p=3.278x10 -5 (Pak1 siRNA), **p=1.91167x10 -5 (Cortactin S113A). 
